Anixa Biosciences Inc

Description

Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body�s immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body�s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immune-therapy drugs which genetically engineer a patient�s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.